Sign in

CIK 0001604464

  • Non-accelerated filer
  • Smaller reporting company

Atara Biotherapeutics, Inc.

Sign in to watch
Ticker
ATRA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
460920988
Phone
+1 805-623-4211
Business address
1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, 91320
Open-market buys, last 90 days
$999,994
in 1 filing
Open-market sales, last 90 days
$39,368
in 1 filing

Net +$960,625. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Cherry Brian N +$1000K Director 1 filing
  2. Nguyen AnhCo −$39K President and CEO sold 5% of stake

Reading 3 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2015-01-16 Haqq Christopher Chief Medical Officer Grant or award +12,400 261,630
2015-01-16 Haqq Christopher Chief Medical Officer Exercise or conversion · Employee Stock Option (Right to Buy) +41,333 41,333
2015-01-16 MCGRATH JOHN Chief Financial Officer Grant or award +12,400 12,400
2015-01-16 MCGRATH JOHN Chief Financial Officer Exercise or conversion · Employee Stock Option (Right to Buy) +41,333 41,333
2015-01-16 Soffer Gad Chief Operating Officer Grant or award +12,400 12,400
2015-01-16 Soffer Gad Chief Operating Officer Exercise or conversion · Employee Stock Option (Right to Buy) +41,333 41,333
2015-01-16 Ciechanover Isaac E. Chief Executive Officer Grant or award +38,000 38,000
2015-01-16 Ciechanover Isaac E. Chief Executive Officer Grant or award · Employee Stock Option (Right to Buy) +126,667 126,667
2015-01-16 WEBER ECKARD Director Grant or award · Non-Qualified Stock Option (Right to Buy) +25,000 25,000
2015-01-16 Gallagher Carol Giltner Director Grant or award · Non-Qualified Stock Option (Right to Buy) +12,500 12,500
2015-01-16 Fust Matthew K Director Grant or award · Non-Qualified Stock Option (Right to Buy) +12,500 12,500
2015-01-16 SEIDENBERG BETH C Director Grant or award · Non-Qualified Stock Option (Right to Buy) +25,000 25,000
2014-10-21 MARCUS JOEL S Director Purchase +9,090 $11.00 $100K 9,090
2014-10-21 SEIDENBERG BETH C Director Conversion +1,852,106 2,599,029
2014-10-21 SEIDENBERG BETH C Director Conversion +55,314 77,621
2014-10-21 SEIDENBERG BETH C Director Conversion · Series A Preferred Stock −1,244,871 0
2014-10-21 SEIDENBERG BETH C Director Conversion · Series B Preferred Stock −607,234 0
2014-10-21 SEIDENBERG BETH C Director Conversion · Series A Preferred Stock −37,179 0
2014-10-21 SEIDENBERG BETH C Director Conversion · Series B Preferred Stock −18,136 0
2014-10-21 Kleiner Perkins Caufield & Byers XV, LLC 10% owner Conversion +1,852,106 2,599,029

Page 68 of 71 · 1,403 trades